Jennifer Sarah Haccoun Abramson combines her business experience with her legal expertise to negotiate commercial deals and provide strategic advice on litigation matters in Canada and the United States. She has been instrumental in designing complex agreements and settling legal disputes by collaborating with multiple stakeholders to find creative solutions. She is licensed to practice law in Quebec and Ontario.

A. Elizabeth Balakhani is Senior Litigation Counsel at GlaxoSmithKline where she handles commercial and product liability matters, as well as internal and government investigations. Prior to joining GSK, Elizabeth practiced at Goodell Devries LLP and Dechert LLP where she focused on representing pharmaceutical, medical device and chemical companies in mass torts, product liability and class action litigation.

Shannon E. Beamer represents pharmaceutical and medical device companies in complex litigation in state and federal courts nationwide. She has been a part of numerous trial teams in national products liability litigation involving several international pharmaceutical manufacturers. Ms. Beamer is a 2013 graduate of the IADC Trial Academy at Stanford Law School, and currently serves as the Young Lawyers Co-Liaison to the Drug and Medical Device Committee within DRI.

Sheila L. Birnbaum practices primarily in the areas of products liability, toxic torts and insurance coverage litigation and is Co-Chair of Quinn Emanuel's Global Product Liability and Mass Torts Practice. Ms. Birnbaum represents corporations in complex mass tort and insurance litigation. Among other significant matters, she secured a historic victory for State Farm Mutual Automobile Insurance Company, when the U.S. Supreme Court reversed a $145 million punitive damages award against the company as unconstitutionally excessive. The New York Times reported that the Court's decision has been hailed as "a major victory in the long-running effort to shield corporate defendants from unconstrained jury awards." The Wall Street Journal characterized the decision as "a big win for business interests concerned about ballooning legal judgments," and the Washington Post described it as "a big win for corporate America."

Lindsey C. Boney IV has a truly varied practice that spans the substantive spectrum. He regularly represents pharmaceutical and medical device companies in national mass tort litigation. In particular, Lindsey has been a member of mass tort national counsel teams, particularly involving regulatory and legal strategy issues. This experience includes serving as lead appellate counsel at trial, briefing all sorts of legal issues in trial and appellate courts (dispositive motions, Daubert motions, and motions in limine), and preparing key regulatory witnesses for deposition. Lindsey has been involved in significant wins in the U.S. Courts of Appeals for the Fifth and Eleventh Circuits, the Iowa Supreme Court, and the Missouri Court of Appeals.

Sheila S. Boston is a litigation partner and member of Arnold & Porter Kaye Scholer LLP's top-ranked Product Liability Group She is a trial lawyer and litigation strategist who defends clients from initiation of the case through trial and creative settlement resolutions. She has successfully litigated before both state and federal courts, and has significant MDL and class action experience. Sheila has been recognized by Who's Who Legal in Product Liability Defense every year since 2012. Sheila serves on her Firm's Recruiting and Pro Bono Committees and as a Vice President of the New York City Bar Association. Sheila is longtime member of DRI's Drug & Medical Device Steering Committee and is currently serving as the Chair of its annual seminar.

The Honorable Denny Chin is a United States Circuit Judge for the Second Circuit. He previously served as a District Judge and as an Assistant United States Attorney in the Southern District of New York. He has practiced at Davis Polk & Wardwell, Campbell, Patrick & Chin, and Vladeck, Waldman, Elias, & Engelhard. He graduated from Princeton University and Fordham Law School. He was born in Hong Kong and was the first Asian American confirmed as an Article III judge outside the Ninth Circuit.

Jenny A. Covington is a Partner at Bowman and Brooke LLP and focuses on defending product liability, class action, mass tort commercial litigation and IP matters for medical device, pharmaceutical, automotive and consumer product manufacturers. She oversees high-profile claims, has chaired four complex trials and played a key role in the California JCCP infusion pump litigation, including a bellwether trial. Jenny has assisted with other major product liability trials and defended numerous appeals. Her medical device practice focuses on issues in general causation, specific causation, preemption and medication administration errors.

Jessica Benson Cox is a member of the Faegre Baker Daniels litigation and advocacy group. She concentrates her practice on the defense of pharmaceutical companies, device manufacturers and other industry leaders in product liability litigation. Jessica has broad experience with overseeing discovery and medical/expert issues in complex product liability, and she has served as national and local counsel in matters involving local anesthetics, anti-psychotic medications, cosmetics, and orthopedic and cardiovascular medical devices.

Jaime L. Dodge is the founding director of Emory's complex litigation institute. Prior to joining Emory, she was a faculty member at Harvard Law School. She brings a unique pragmatic approach to her work, having practiced for a number of years with Paul Hastings and Gibson Dunn, where she focused on high-stakes complex litigation appeals and settlements. Her scholarship focuses on how the structure of procedural regimes affects the exercise of rights and enforcement of substantive law.

David E. Dukes is a partner of Nelson Mullins Riley & Scarborough in the Columbia, South Carolina office. He is a past president of DRI and Lawyers for Civil Justice. David has served as national trial counsel for many companies and has tried cases throughout the country. He is a Fellow of the American College of Trial Lawyers and the International Academy of Trial Lawyers.

Lisa M. Floro is Associate General Counsel for Litigation at Coloplast Corp. She manages all product liability litigation for the company. Prior to her work at Coloplast, Ms. Floro worked in-house at a Life Sciences company managing a variety of litigation, including pharmaceutical mass tort multi-district litigation, commercial litigation, contract/warranty litigation and general litigation, as well as government subpoenas and investigations. She has counseled on regulatory, marketing, medical communications and public relations relating to litigation matters. Her career includes a federal clerkship, private practice in both large and small firms, and in-house counsel. Ms. Floro lives in Pittsburgh, Pennsylvania, and is involved in many community activities. She recently transitioned off the board for the Greater Pittsburgh Community Food Bank and sits on the Mission Advancement Committee for the Food Bank. She received her undergraduate degree from the University of Pittsburgh, and her J.D. from Duquesne University School of Law. She is a member of the American Bar Association, Association of Corporate Counsel and International Association of Defense Counsel.

Sara J. Gourley, a litigation partner in Sidley Austin's Chicago office, is head of the Products Liability Group and served on the firm's Executive Committee for many years. Sara's practice is focused on pharmaceutical and medical device defense, especially multi-jurisdictional coordination and defense of class actions. She has played leading defense roles in some of the pharmaceutical industry's most significant products liability litigation and is consistently recognized by top ranking publications, including Chambers, Legal 500, LMG Life Sciences, and many others. She is the committee chair of this seminar.

James K. Grasty joined Merck in 2006 to manage the Vioxx product liability litigation and related cases. Currently, James supervises Merck's Litigation, Government Investigations, Global Labor and Employment, Environmental Health and Safety and the MMD Regulatory practice teams. James has over two decades of experience as an in-house and former law-firm attorney representing corporate and institutional clients in the defense of a wide range of high visibility matters in the areas of product liability, consumer fraud, mass tort, employment and complex commercial litigation, much of which has been centralized in federal multi-district litigation proceedings. Prior to joining Merck, James was a Vice President and Associate General Counsel at GlaxoSmithKline where he was responsible for counseling, training, investigations and managing the defense of product liability, commercial and employment matters. He also amassed significant alternative dispute resolution experience culminating in the successful pre-trial conclusion of a broad range of claims, lawsuits and class actions. Before joining GSK, James was an associate in the Commercial practice group of Stradley, Ronon Stevens & Young in Philadelphia and an Assistant City Solicitor in the Special Litigation Unit of the Philadelphia City Solicitor's Office, where he began his legal career. James received his JD from Temple University School of Law and earned his undergraduate degree from Brown University.

Bruce A. Green is the Louis Stein Chair at Fordham Law School, where he directs the Louis Stein Center for Law and Ethics. He teaches and writes in the areas of legal ethics and criminal law, and has co-authored a casebook, Professional Responsibility: A Contemporary Approach (West, 3d ed. 2017). He chairs the New York City Bar's Committee on Professional Ethics, serves on the Multistate Professional Bar Examination drafting committee, and is a member and past chair of the NY State Bar Association's Committee on Professional Ethics. He previously chaired the ABA Criminal Justice Section, served on the ABA Standing Committee on Ethics and Professional Responsibility, was the Reporter to both the ABA Task Force on Attorney-Client Privilege and the ABA Commission on Multijurisdictional Practice, and co-chaired the ethics committees of the ABA Litigation Section and the ABA Criminal Justice Section. Since joining the Fordham faculty in 1987, Professor Green has also engaged in various part-time public service, including as a member of the New York City Conflicts of Interest Board, as a member of the attorney disciplinary committee in Manhattan, as Associate Counsel in the office of the Iran/Contra prosecutor, and as a consultant and special investigator for the NYS Commission on Government Integrity. Previously, Professor Green was a federal prosecutor in the Southern District of New York, where he served as Chief Appellate Attorney, and he was a judicial law clerk to Justice Thurgood Marshall and Circuit Judge James L. Oakes. He is a graduate of Princeton University and Columbia Law School

Markus Green serves as an Assistant General Counsel, for Pfizer, Inc., the world's largest Pharmaceutical Company. At Pfizer, Mr. Green helps lead the Government Litigation Group of the Legal Department. As part of Government Litigation, Mr. Green works with local, state and federal prosecutors both nationally and internationally in an effort to defend Pfizer's interest in government initiated litigation and investigations. Mr. Green is also responsible for several special initiatives at Pfizer including Civil Justice Reform, managing the Attorney General Outreach Program and handling Congressional Inquiries and Investigations. Prior to joining Corporate America, Mr. Green spent nearly a decade in public service. Mr. Green was the Executive Assistant Attorney General for the State of New Jersey serving as Chief of Staff under Attorney General Peter C. Harvey. In that capacity Mr. Green was part of the Attorney General's Executive Staff assisting in the supervision of the over 9,000 employees that comprise the Department of Law and Public Safety. In addition to his supervisory role, Mr. Green managed complex Civil and Criminal Litigation matters.

Nefertiti Greene is President, Global Wound Closure & Repair, at Ethicon, a division of the Johnson & Johnson family of companies. In this role, Nefertiti leads a $3B+ global surgical platform encompassing suture and repair, hernia and women's health while also overseeing the Ethicon global pricing and digital organizations. Nefertiti is also a member of the Ethicon global management board. Prior to joining Ethicon, Nefertiti was President of Janssen Therapeutics, where she led the U.S. infectious diseases commercial organization, the Janssen NA Digital CoE, and was a member of the Janssen Americas Leadership Team. Nefertiti is a healthcare leader with over 24 years of industry experience spanning pre-clinical research, clinical research and commercial operations. Prior to joining J&J, Nefertiti was Vice President, Country Division Head of Diabetes Care at Bayer HealthCare. Nefertiti earned a Bachelor of Science degree in Biology/Chemistry from the State University of New York at Albany, and a Master of Public Health in Biostatistics from New York Medical College.

Jason Rhae Harmon defends pharmaceutical, medical device and other product manufacturers. A significant portion of his practice is in complex and multidistrict litigation. In his MDL practice, Jason has successfully defended clients from broad ESI discovery requests and aggressively sought discovery from opposing parties both on an MDL-wide basis and in specific bellwether cases. Fluent in Spanish, he has unique insight into the discovery challenges of cross-border disputes. Jason received his J.D. from the University of Kansas School of Law.

Daniel Healey is a Corporate Counsel in the Civil Litigation Group of Pfizer Inc. He manages a broad range of civil litigation matters and provides strategic legal support to Pfizer business units. Prior to joining Pfizer, he practiced at Arnold & Porter LLP in Washington, D.C. He is a graduate of the University of Virginia School of Law and Williams College. Prior to law school, he covered the pharmaceutical industry as a reporter and finance editor.

Michael-Bryant Hicks is an executive and lawyer with more than 15 years' experience, a deep understanding of complex legal issues and extensive background in international business, acquisitions, and healthcare regulatory affairs. Mr. Hicks holds a bachelor's degree in psychology from the University of North Carolina at Chapel Hill and a Juris Doctor from Yale Law School. As a Fulbright Scholar, he also worked on small business incubation projects in Quito, Ecuador.

Timothy E. Hudson is a partner in the Dallas, Texas office of Thompson & Knight LLP. He has a broad litigation practice helping clients navigate complex legal challenges in federal and state courts. His practice frequently involves the defense of pharmaceutical and medical device companies in product liability litigation. Mr. Hudson currently serves as national coordinating counsel for a worldwide medical device manufacturer, responsible for coordinating with defense counsel on discovery, witness preparation and trial strategy.

Robert S. Jett III is a data privacy and compliance attorney and was recently Senior Legal Counsel – Information Services for Stryker Corporation. Providing advice and strategic support for information services, data protection and privacy in insurance, healthcare and related international business operations, he has been working with IT, Data Privacy and Protection, Information Security and Corporate Compliance areas for more than 20 years as in house corporate and compliance counsel in both U.S. domestic and international operations.

David N. Kelley, a co-leader of the white collar and securities litigation practice of Dechert LLP and former United States Attorney for the Southern District of New York, has cultivated a revered reputation for his defense of high-profile matters involving sensitive white collar litigation and investigations before major regulatory bodies. His more than three decades of experience span a diverse range of commercial litigation and federal securities as well as grand jury investigations, prosecutions and congressional inquiries. As an experienced trial lawyer and investigator, Mr. Kelley represents multinational and domestic public companies, boards of directors, audit committees, and individuals, including officers and directors, on issues arising across a broad spectrum of industries, including defense, energy, healthcare, pharmaceuticals, financial services, infrastructure, insurance, oil and gas, and retail. Lauded as a brilliant enforcement lawyer, Mr. Kelley advises clients around the globe on complex business crime disputes and litigates high-stakes external investigations before federal and state government regulators and prosecutors. (Chambers USA 2016) He has appeared in courts and before regulatory bodies across the United States, and abroad, including the SEC, DOJ, Department of the Treasury, Office of Foreign Assets Control, Office of the Comptroller of the Currency, the Federal Reserve Bank, State Attorneys General, Inspector Generals of various government agencies, and the UK Financial Conduct Authority. Mr. Kelley also has significant experience conducting a variety of internal investigations concerning accounting fraud and irregularities, earnings management, option backdating, commercial bribery, and personnel misfeasance.

Deirdre R. Kole is Senior Counsel, Litigation at Johnson & Johnson. She joined the company in 2016 and is responsible for the management of product liability litigation involving certain medications, medical devices, and over-the-counter products. Prior to joining Johnson & Johnson, Deirdre was a partner at Drinker Biddle & Reath where her practice focused on the defense of pharmaceutical companies and medical device manufacturers in product liability litigation.

Harry Kovelman, M.D. is Vice President of Medical Affairs for Helius Medical Technologies where he focuses on the development of non-opioid products for postsurgical pain control. Additionally, Dr. Kovelman leads a national initiative where grassroots physicians come together at a locally hosted meeting to discuss reduction strategies for the opioid burden in both hospitals and in communities. These programs encompass a comprehensive program to educate on the use of opioids and their unintended consequences.

Glenn G. Kuper, Jr., Ph.D. has a wealth of practical experience in persuasion and argument, based on years of experience in litigation consulting and a firm theoretical foundation in communication studies. Dr. Kuper has worked on a variety of cases, including multiple national product defect cases. He has participated in weeks-long voir dires, managed numerous mock trials, and engaged in witness preps across the country. Dr. Kuper has an M.A. and Ph.D. in speech communication from the University of Washington.

Corena G. Larimer represents pharmaceutical and medical device companies in complex civil litigation in California and throughout the United States. She has significant experience handling complicated legal and regulatory matters in trial and appellate courts. She currently serves as the Young Lawyers Co-Liaison to the Drug and Medical Device Committee.

Donald C. Le Gower is Senior Counsel at Bristol-Myers Squibb Co. in Lawrenceville, NJ

Bradley E. Lerman became Senior Vice President, General Counsel and Corporate Secretary at Medtronic in May of 2014. In addition to leading the company's global legal function, he directs the Medtronic government affairs department and serves as a member of the Medtronic Executive Committee. Brad came to Medtronic from the Federal National Mortgage Association (Fannie Mae), where he was Executive Vice President, General Counsel and Corporate Secretary. Previously he served as Senior Vice President, Associate General Counsel and Chief Litigation Counsel for Pfizer, where he led the company's product and commercial litigation, government investigations and patent litigation teams. Lerman also has extensive experience as a private practice attorney; he served as Litigation Partner at Winston & Strawn LLP in Chicago, where he co-chaired the firm's white collar defense practice group. He has also been a federal prosecutor for the U.S. Department of Justice, serving eight years as an Assistant U.S. Attorney in the Northern District of Illinois. In all, he brings 25 years of legal experience in the public and private sectors to Medtronic. Lerman received his Juris Doctor from Harvard Law School, where he graduated cum laude, and his bachelor's degree in economics from Yale University, where he graduated summa cum laude. He was also an adjunct professor at Northwestern University School of Law.

Ted J. McDonald III, is a founding partner of McDonald Davidson PA in Overland Park, Kansas. He practices in a variety of areas of civil litigation with a primary emphasis on defending and consulting long term care and assisted living facilities. Ted serves as counsel for some of the largest providers of long term care services in the country. Mr. McDonald's background includes experience in products liability, medical malpractice and personal injury litigation. Mr. McDonald is a member of both the Missouri and Kansas Bars and is admitted to practice in the United States District Courts in Missouri and Kansas. Ted is a member of the International Association of Defense Counsel (IADC) and holds numerous positions of leadership with the Defense Research Institute (current member, DRI Law Institute; past Chair, DRI Medical Liability and Healthcare Law Committee; past Chair, DRI Nursing Home-ALF Subcommittee; past member, DRI Governance Committee; past Chair, DRI Young Lawyers' Committee; past Faculty, DRI Nursing Home and Medical Liability Seminars). Mr. McDonald is the Law Institute liaison for this seminar.

Madeleine M. McDonough is Chair and Partner at Shook, Hardy & Bacon, and represents multinational companies in pharmaceutical, animal health, medical device, food, cosmetics and beverage industries. The National Association of Women Lawyers honored Madeleine with its 2017 Leadership Award, and The National Law Journal named Madeleine one of the nation's top 50 Litigation Trailblazers & Pioneers. During her tenure as chair of Shook's Pharmaceutical and Medical Device Practice, the firm represented dozens of pharmaceutical companies, including the top 10 worldwide.

Lynn Mehler is a partner in the Pharmaceutical and Biotechnology practice at Hogan Lovells. She advises clients on a range of FDA and DEA regulatory matters. Drawing on her 12 years with the FDA's Office of the Chief Counsel, Lynn has a deep understanding of the FDA. She has worked extensively on the approval processes for new drugs and biologics; on safety issues that include Risk Evaluation and Mitigation Strategies (REMS); and on unique regulatory issues raised during the development and marketing of controlled substances.

Kevin L. Ong, PhD, PE provides engineering consulting services related to product liability and intellectual property litigation matters, as well as product design consulting services to the medical device industry. His background is in failure analysis of medical devices, with a focus on how patient, surgical, and device factors influence performance. He has testified in matters related to pelvic mesh, orthopaedic implants, cold therapy, medical equipment, and surgical instruments. Kevin received his Ph.D. from Cornell University. He is also a licensed Professional Engineer.

Thomas R. Pack is an associate at Maslon LLP and represents businesses in product liability litigation, complex intellectual property disputes, and suits involving labor and employment issues in the technology industry. He helps clients navigate all stages of the litigation process throughout many forums, including federal and state courts, mediation, and arbitration. Tom also maintains an active pro bono practice in the civil rights and immigration law fields. Before joining Maslon, Tom was a litigator at Gibson, Dunn & Crutcher LLP in San Francisco.

Teri H. Peeples is an associate in Sidley Austin's New York Product Liability & Mass Torts practice. Teri represents pharmaceutical and life sciences clients in federal and state courts, including in multi-district litigation. She counsels clients on risk identification and mitigation strategies for drugs and consumer products, and she conducts FCPA risk assessments and internal investigations for pharmaceutical companies. Teri received her J.D. from Emory University School of Law and her B.A. from Amherst College.

Anna S. Richo joined UCB, a global biopharmaceutical company headquartered in Belgium, as Executive Vice President & General Counsel in 2012. Ms. Richo has global responsibility for legal, intellectual property, ethics and compliance, and corporate secretariat maters. Previously, Ms. Richo spent 9 years at Amgen Inc., where her most recent positon was Senior Vice President and Chief Compliance Officer. Ms. Richo began her career in healthcare with Baxter Healthcare Corporation, where she consummated a 12-year career as Vice President, Law for the Bioscience business. Ms. Richo formerly served as a member of the Board of Directors of Cytec Corporaton (NASDAQ:CYTC), a medical diagnostics company, from 1998 – 2003, subsequently acquired by Hologic Inc. Ms. Richo received her Juris Doctor degree from DePaul University, College of Law and her Bachelor of Science degree in Industrial and Labor Relations from Cornell University.

Gail Rodgers is a partner in the New York City office of DLA Piper. She concentrates her practice in pharmaceutical and medical device litigation, mass torts and government and internal investigations. Gail represents clients on a wide variety of compliance matters, including the Foreign Corrupt Practices Act (FCPA) as well as advising and enhancing compliance programs in response to investigations. Gail has extensive experience in a wide variety of state and federal litigation, including providing strategic advice at each stage of litigation, managing national discovery teams, and implementation of national resolution programs.

Alan E. Rothman is Counsel at Arnold & Porter Kaye Scholer LLP, with a focus on MDL, class action and individual mass tort product liability litigation, including jurisdictional and coordination issues. Alan also oversees settlements and counsels clients with respect to corporate structure, MMSEA and legal ethics issues. Over the past several years, Alan has authored, or been quoted in, more than 50 articles regarding MDL practice and jurisdictional issues and presented more than half a dozen CLEs.

Joan M. Schmidt is an internationally experienced executive in the life science industry who has worked in various sectors including pharmaceuticals, medical devices and industrial biotechnology. Joan is currently Executive Vice President, General Counsel and Secretary at Biotronik, Inc., a leading innovator of cardio- and endo-vascular medical devices. Headquartered in Berlin, Biotronik has more than 6,000 employees globally in over 100 countries, and production and research and development facilities in Germany, US, Switzerland and Singapore. Joan joined Biotronik in 2015 and has responsibility for Legal Affairs and Human Resources for Biotronik's US business. Before joining Biotronik, Joan had a 20-year career at Novo Nordisk, a Fortune 100 company and global leader in the treatment of diabetes, obesity and bleeding disorders. After 8 years as Deputy General Counsel in Novo Nordisk's US operations, Joan transferred to corporate headquarters in Copenhagen. As Corporate Vice President in Legal Affairs, Joan had global responsibility for litigation/government investigations, corporate transactions and trademarks and played a key role in the creation of a global legal team of 140+ legal professionals in 27 countries.

Erik W. Snapp defends pharmaceutical, medical device, automotive and consumer products clients in consumer fraud class actions and product liability/mass tort litigation. He also handles regulatory and internal investigations in the United States and Europe, and has advised clients on compliance and ethics programs. He has been recognized by The Legal 500 US for his product liability and mass tort defense practice in the areas of consumer products, pharmaceuticals and medical devices, and toxic tort.

Brett A. Tarver is an associate at Jones Day in the Atlanta, Georgia office. Her practice focuses on complex civil litigation in state and federal courts, including the defense of individual and class action product liability lawsuits. She is a Steering Committee member of DRI's Young Lawyers Committee and is an active member of the DRI Drug and Medical Device Committee.

Craig A. Thompson is a partner at Venable LLP, and a seasoned trial lawyer with over 20 years' experience trying civil cases before federal and state courts throughout the United States. He has served as national trial counsel, coordinating counsel and as a subject-matter team member for national and international corporations and manufacturers. Craig was recently recognized as a Top 100 Trial Lawyer by Benchmark Litigation, and is listed in Chambers USA, Super Lawyers and Best Lawyers in America. He is a member of DRI, the Product Liability Advisory Council, and an elected member of ABOTA. Craig is president-elect of the International Association of Defense Counsel (IADC). The IADC is the preeminent invitation-only global legal organization for attorneys who represent corporate and insurance interests. Founded in 1920, the IADC's members hail from six continents, 51 countries and territories, and all 50 U.S. states. He also serves on the board of trustees of the University of Maryland College Park Foundation and the University of Maryland Children's Hospital. At Venable, Mr. Thompson is a member of the firm's board of directors and the former chair of the firm's Diversity Committee.

Charissa N. Walker, an attorney with Tucker Ellis LLP, defends pharmaceutical and medical device manufacturers in product liability claims. Charissa defends actions in state and federal courts, including MDLs involving thousands of claims – all the way to jury verdict. She has experience conducting and defending depositions, arguing motions, and negotiating favorable settlements. Before joining Tucker Ellis, Charissa clerked in the U.S. District Court for the Northern District of Ohio. She received her J.D. summa cum laude from Cleveland-Marshall College of Law.

Wendy Weiss is a Managing Director with Navigant Consulting's Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations Segment. Prior to joining Navigant in 2014, Ms. Weiss was the Chief of the Civil Fraud Section of the US Attorney's Office for the Central District of California (Los Angeles) and, prior to that, its Health Care Fraud Coordinator. Ms. Weiss spent close to 20 years prosecuting or supervising healthcare False Claims Act cases against medical providers including physicians and physician practices, health care systems, hospitals, skilled nursing facilities, home health agencies, pharmaceutical and medical device companies and pharmacy chains. Ms. Weiss primarily focuses her practice on assisting and strategizing with law firms and their healthcare industry clients in performing internal investigations in response to federal, state, and regulatory investigations and providing compliance advice to the healthcare industry. She builds and manages teams of experts to address allegations raised in False Claims Act, qui tam, anti-kickback statute, healthcare, and white collar actions. Ms. Weiss graduated from the University of Pennsylvania (BA in psychology) and the George Washington University (JD).

Kacy Elizabeth Wiggum is a senior attorney at Novo Nordisk Inc. Her responsibilities include management of complex product liability and commercial matters, as well as government investigations. She also counsels the business on various regulatory, transactional and legal issues by providing support to key marketing, sales and commercial operations functions. Prior to joining Novo Nordisk, Kacy practiced as an attorney for Arnold & Porter Kaye Scholer LLP in New York, NY.

Beth A. Wilkinson is a founding partner at Wilkinson Walsh Eskovitz LLP, with 30 years of experience and an unrivaled record of victories in both federal and state courts throughout the country, Beth is a trial lawyer who routinely serves as lead counsel in bet-the-company, high-stakes trials. Her clients include Altria, Bayer, Facebook, Federal Express, Georgia Pacific, Medtronic, MLB, NCAA, NFL, and Pfizer. Beth is a Fellow of the American College of Trial Lawyers. She also was recently named a Litigator of the Year by The American Lawyer, a Law360 Trial Ace, a National Law Journal Winning Litigator, and was the 2015 recipient of Chambers' prestigious Business Trial Lawyer of the Year award. Beth received her B.A. magna cum laude from Princeton University and her J.D. from the University of Virginia School of Law.

Maryanne C. Woo is a partner in the Chicago office of Reed Smith LLP. She is a member of the firm's Complex Litigation Group with a focus on medical device product liability and mass tort litigation. Ms. Woo is also the head of the Reed Smith's Internet of Things Working Group, a cross-disciplinary team focused on solving legal issues arising from this emergent technology.